首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Efficacy and safety of mifepristone-misoprostol combination with extraamniotic ethacridine lactate-misoprostol for termination of second trimester pregnancy
【24h】

Efficacy and safety of mifepristone-misoprostol combination with extraamniotic ethacridine lactate-misoprostol for termination of second trimester pregnancy

机译:米非司酮-米索前列醇联合羊水外依他ha啶乳酸盐-米索前列醇终止中期妊娠的疗效和安全性

获取原文
       

摘要

Background: Mid trimester termination of pregnancy is one of the most controversial areas of gynecological practice. It has moral, emotional, social and technical issues. This study was designed for comparison of efficacy and safety of Mifepristone-Misoprostol combination with exrtaamniotic Ethacridine Lactate-misoprostol for termination of second trimester pregnancy. Methods: The present was undertaken among the patients admitted to hospitals attached to J.J.M. Medical College; Bapuji hospital, Women and Children hospital and Chigateri general hospital Davangere during the study period from November 2016 - October 2017. Patients coming for second trimester abortion to above mentioned hospitals were assigned serial number from 1 to 80 and all patients with even number will be allocated to group 1 and all patients with odd number will be allocated in group 2, each group comprising 40 women each. Results: Majority of the cases in both the groups were between 21-25 yrs. Majority of the cases in both the groups were multigravidas. 11 cases from group 1 and 12 cases from group 2 were of gestational age between 14-16 wks. 29 cases from group 1 and 28 cases from group 2 were of gestational age between 18-20 wks. In the present study the mean induction abortion interval for group 1 was 19.56±1.82 hours and group 2 was 14.13±2.72 hours. This was statistically significant. Of the 40 cases in each group, 37 had complete abortion i.e. 92.5% 3 cases (7.5%) from both the groups had incomplete abortion. The side effects were relatively more in more in group 1 when compared to group 2. Conclusions: It was concluded that with this combination success rate was high (92.5 %), with Short induction abortion interval, less rate of incomplete abortion without any major complications.
机译:背景:妊娠中期终止是妇科实践中最具争议的领域之一。它有道德,情感,社会和技术问题。这项研究旨在比较米非司酮-米索前列醇与羊膜炎性乳酸依沙cr啶乳酸-米索前列醇联合终止中期妊娠的疗效和安全性。方法:本研究是在J.J.M.医学院;研究期间为2016年11月至2017年10月的Bapuji医院,妇女儿童医院和Chigateri综合医院Davangere。将向上述医院中流产的患者分配序列号从1到80,所有偶数患者将被分配进入第1组,所有奇数患者将分配到第2组,每组包括40名女性。结果:两组中的大多数病例在21-25岁之间。两组中大多数病例为多胎妊娠。第1组的11例和第2组的12例的胎龄在14-16周之间。第1组的29例和第2组的28例的胎龄在18-20周之间。在本研究中,第1组的平均诱导流产间隔为19.56±1.82小时,第2组为14.13±2.72小时。这具有统计学意义。每组40例中,有37例完全流产,即92.5%,两组中3例(7.5%)均未完全流产。与第2组相比,第1组的副作用相对更多。结论:结论是,采用这种组合的成功率很高(92.5%),诱导流产间隔短,不完全流产发生率低,没有任何重大并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号